| Literature DB >> 27242758 |
Abstract
Tailed phages with genomes of larger than 200 kbp are classified as Jumbo phages and exhibited extremely high uncharted diversity. The genomic annotation of Jumbo phage is often disappointing because most of the predicted proteins, including structural proteins, failed to make good hits to the sequences in the databases. In this study, 23 proteins of a novel Bacillus Jumbo phage, vB_BpuM_BpSp, were identified as phage structural proteins by the structural proteome analysis, including 14 proteins of unknown function, 5 proteins with predicted function as structural proteins, a glycoside hydrolase, a Holliday junction resolvase, a RNA-polymerase β-subunit, and a host-coding portal protein, which might be hijacked from the host strain during phage virion assembly. The glycoside hydrolase (Gp255) was identified as phage virion component and was found to interact with the phage baseplate protein. Gp255 shows specific lytic activity against the phage host strain GR8 and has high temperature tolerance. In situ peptidoglycan-hydrolyzing activities analysis revealed that the expressed Gp255 and phage structural proteome exhibited glycoside hydrolysis activity against the tested GR8 cell extracts. This study identified the first functional individual structural glycoside hydrolase in phage virion. The presence of activated glycoside hydrolase in phage virions might facilitate the injection of the phage genome during infection by forming pores on the bacterial cell wall.Entities:
Keywords: glycoside hydrolase; jumbo bacteriophage; structural proteome
Year: 2016 PMID: 27242758 PMCID: PMC4870245 DOI: 10.3389/fmicb.2016.00745
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains and plasmids used in this study.
| GR8 | Peng et al., | |
| BL21(DE3) | F− | Novagen |
| M15 | Qiagen | |
| pET-28a(+) | Expression vector; Kanr, C/N-terminal His tag/thrombin/T7 tag, T7
| Novagen |
| pET/ | Kanr, | This study |
| pET/ | Kanr, 3′ termini 642 bp of | This study |
| pET/ | Kanr, 5′ termini 567 bp of | This study |
| pQE30 | Expression vector; Ampr, N-terminal His tag, T5
| Qiagen |
| pQE/ | Ampr, | This study |
| GAGGATCCAAAGGTACAGTTGACG, forward primer to amplify | This study | |
| GCGTCGACAATACCATTAATTAGAC, reward primer to amplify | This study | |
| GCGTCGACAATACCATTAATTAGAC, reward primer to amplify | This study | |
| GAGGATCCAAAGGTACAGTTGACG, forward primer to amplify | This study | |
| GAGGATCCATGAATGATTTTAAGG, forward primer to amplify | This study | |
| CTGTCGACCTATAAATATATTTTTG, reward primer to amplify | This study | |
Characteristic of the vB_BpuM_BpSp virion proteome identified by HPLC-ESI_MS/MS.
| Gp2 | 28.1 | 2 | 6.3 | Hypothetical protein |
| Gp25 | 101.1 | 8 | 9.3 | Virion structural protein |
| Gp28 | 35.3 | 5 | 17.4 | Hypothetical protein |
| Gp31 | 19.3 | 4 | 4.2 | Hypothetical protein |
| Gp133 | 38.5 | 5 | 17.7 | Major virion structural protein |
| Gp196 | 35.2 | 5 | 14.2 | Hypothetical protein |
| Gp197 | 60.8 | 8 | 15.2 | Structural protein precursor |
| Gp202 | 111.9 | 13 | 15 | Contractile tail sheath protein |
| Gp203 | 29.7 | 6 | 27.5 | Hypothetical protein |
| Gp208 | 104.6 | 8 | 9.3 | Hypothetical protein |
| Gp212 | 58.7 | 6 | 13.9 | RNA polymerase β-subunit |
| Gp214 | 15.9 | 3 | 19.6 | Hypothetical protein |
| Gp218 | 11.6 | 3 | 29.6 | Hypothetical protein |
| Gp223 | 38.5 | 3 | 11.6 | Hypothetical protein |
| Gp255 | 43.3 | 6 | 14.9 | Glycoside hydrolase |
| Gp265 | 24.9 | 2 | 8.6 | Holliday junction resolvase |
| Gp271 | 39 | 6 | 26.2 | Hypothetical protein |
| Gp272 | 41 | 11 | 31.3 | Hypothetical protein |
| Gp287 | 16 | 2 | 30.9 | Baseplate protein |
| Gp299 | 15 | 5 | 23.5 | Hypothetical protein |
| Gp307 | 10.8 | 2 | 12.2 | Hypothetical protein |
| Gp316 | 25.2 | 2 | 10.3 | Hypothetical protein |
| 34.2 | 5 | 19.2 | Phage portal protein |
GenBank accession number of the proteins from host strain GR8.
Figure 1Proteomic analysis of the structural proteins of phage vB_BpuM_BpSp. The phage purified by sucrose density gradient centrifugation was analyzed by SDS-PAGE and the protein bands were further identified by HPLC-MS/MS. The molecular weight standard is indicated on the left. The corresponding CDSs, the predicted functions, and the predicted molecular mass of the proteins identified by mass spectrometry were also indicated.
Figure 2Schematic diagram of Gp255 and amino acid sequence alignment of the LysM domains. (A) The domain composition of Gp255 analyzed by using Pfam and the positions of the amino acid residues at the end of each domain are indicated. The N-terminal catalytic domain and C-terminal cell wall binding domains are shown. (B) Alignment of the catalytic domain of Gp255 and endolysin Psm (PDB database accession number 4KRU_A) from phage phiSM101. The catalytic site residues of endolysin Psm are indicated in red box. (C) Alignment of the amino acid sequence of the three LysM domains from Gp255 and the three LysM domain from fungal efector Ecp6 (PDB database accession number 4B8V_A). The positions of the three peptides in Gp255 and Ecp6 are indicated. The two chitin-binding sites in LysM1 and LysM3 of Ecp6 are indicated with a blue line and a green line. The chitin-binding sites of LysM2 of Ecp6 are indicated in red box. The sequences were aligned by ClustalW 2.0.
Figure 3Characterization of protein Gp255. (A) SDS-PAGE analysis of purified Gp255, Gp255N, Gp255C, and E. coli strain BL-21. (B) In-gel lytic activities of proteins Gp255, Gp255N, Gp255C, and E. coli strain BL-21. The purified proteins were mixed with loading buffer for use. (C) The influence of protein concentration on the lytic curve of Gp255. Gp255 was used at different concentration and the test was carried out at 37°C. (D) Temperature tolerance of Gp255. Gp255 at a concentration of 10 μM was treated at different temperatures for 10 min and the treated proteins were used for lytic activity evaluation at a final concentration of 0.05 μM. The cells treated with PBS solution was used as control (indicated as “Con”). (E) Lytic activity of Gp255 against B. pumilus strain GR8. The strain GR8 was observed by optical microscope at 0, 1, 2, and 10 min after treatment and the time of observation is indicated. The purified Gp255 was used with a final concentration of 0.05 μM and the tests were carried out at 37°C.
Figure 4Lytic specificity of Gp255. (A) Lytic activity of Gp255 against eight tested strains. The suspension of exponential-growth GR8 without adding Gp255 was used as control. For the Gram-negative strain, EDTA was added into the reaction buffer at a concentration of 1 mM. (B) In-gel lytic activity assay of Gp255. The crude cell extracts of six strains were used.
Figure 5Analysis of peptidoglycan-hydrolyzing activities of phage vB_BpuM_BpSp. The purified phage vB_BpuM_BpSp was mixed with loading buffer and boiled at 100°C for 10 min before separating them by SDS-PAGE. The purified Gp255 was mixed with loading buffer. After that, the unboiled (indicated as “Gp255”) and boiled (indicated as “Boiled Gp255”) proteins were separated by SDS-PAGE. The sterilized crude cell extracts of GR8 was added into the gel for lytic activity assay. The lane loaded with 1 × Loading buffer were used as control.
Figure 6Identification of the phage structural protein that interacted with Gp255. (A) Identification of the interacting protein of Gp255 in phage vB_BpuM_BpSp structural proteome. The virions of phage vB_BpuM_BpSp were separated by SDS-PAGE and biotin-labeled Gp255 was used for Far-western blotting analysis. The detected protein band was identified by MALDI-TOF/-TOF MS. The identified peptide and corresponding protein encoded by phage vB_BpuM_BpSp are indicated. (B) Verification of the interaction between Gp255 and Gp287. Purified Gp287 were separated by 15% SDS-PAGE. E. coli strain BL-21/pET28a was used as control. Western blotting was carried by using the antibody of 6 × His-tag and the biotin-labeled Gp255, respectively. The detected hybridization bands are indicated.